Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis

• Main Authors: Jincheng Wang (Author), Kaili Hu (Author), Xuanyan Cai (Author), Bo Yang (Author), Qiaojun He (Author), Jiajia Wang (Author), Qinjie Weng (Author)
• 格式: 圖書
• 出版: Elsevier, 2022-01-01T00:00:00Z.
• 主題: article
• 在線閱讀: Connect to this object online.

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrotic interstitial pneumonia with unknown causes. The incidence rate increases year by year and the prognosis is poor without cure. Recently, phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB/AKT) signaling pathway can be consi...